Compare · OPCH vs PRVA
OPCH vs PRVA
Side-by-side comparison of Option Care Health Inc. (OPCH) and Privia Health Group Inc. (PRVA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OPCH and PRVA operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- PRVA is the larger of the two at $3.51B, about the same size as OPCH ($3.41B).
- Over the past year, OPCH is down 29.3% and PRVA is up 33.5% - PRVA leads by 62.9 points.
- PRVA has been more active in the news (9 items in the past 4 weeks vs 3 for OPCH).
- PRVA has more recent analyst coverage (25 ratings vs 15 for OPCH).
- Company
- Option Care Health Inc.
- Privia Health Group Inc.
- Price
- $21.69+0.60%
- $27.89+1.53%
- Market cap
- $3.41B
- $3.51B
- 1M return
- +1.47%
- +21.72%
- 1Y return
- -29.30%
- +33.55%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 3
- 9
- Recent ratings
- 15
- 25
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Privia Health Group Inc.
Privia Health Group, Inc. operates as a physician practice management and population health technology company in the United States. The company comprises regional medical groups, accountable care organizations, and specialty verticals. It offers technology and population health tools to enhance independent providers' workflows; management service organization that enables providers to reduce administrative work focus on their patients; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; physician-led accountable care organization, which engages patients, reduces inappropriate utilization, and enhances coordination and patient quality metrics to drive value-based care and transform the healthcare delivery system; and network for purchasers and payers. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. operates as a subsidiary of Brighton Health Group Holdings, LLC.
Latest OPCH
- Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call
- EVP Sp Sales & Solutions Bhatia Prateek was granted 39,795 shares (SEC Form 4)
- SEC Form 3 filed by new insider Bhatia Prateek
- Goldman initiated coverage on Option Care Health with a new price target
- Option Care Health Appoints Robert Okunski as Vice President, Investor Relations
- Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking
- Director Bierbower Elizabeth D was granted 8,997 shares, increasing direct ownership by 38% to 32,871 units (SEC Form 4)
- Director Deckmann Natasha was granted 9,841 shares, increasing direct ownership by 44% to 32,002 units (SEC Form 4)
- Director Kraemer Harry M Jansen Jr was granted 21,076 shares, increasing direct ownership by 5% to 471,076 units (SEC Form 4)
- Director Pate R Carter was granted 8,997 shares, increasing direct ownership by 77% to 20,620 units (SEC Form 4)
Latest PRVA
- EVP & Chief Financial Officer Mountcastle David sold $588,679 worth of shares (21,275 units at $27.67) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 164,853 units (SEC Form 4)
- EVP & Chief Financial Officer Mountcastle David sold $16,542 worth of shares (600 units at $27.57) as part of a pre-agreed trading plan, decreasing direct ownership by 0.32% to 186,128 units (SEC Form 4)
- Privia Health Group Inc. filed SEC Form 8-K: Leadership Update
- Director Morris Matthew Shawn exercised 112,759 shares at a strike of $2.00 and sold $3,076,868 worth of shares (112,759 units at $27.29) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 68,188 units (SEC Form 4)
- EVP & Chief Financial Officer Mountcastle David sold $680,185 worth of shares (24,734 units at $27.50) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 186,728 units (SEC Form 4)
- Privia Health to Report Second Quarter 2026 Results on Thursday, August 6
- Director Morris Matthew Shawn exercised 135,498 shares at a strike of $2.00 and sold $3,566,335 worth of shares (135,498 units at $26.32) as part of a pre-agreed trading plan (SEC Form 4)
- Director Morris Matthew Shawn exercised 151,322 shares at a strike of $2.00 and sold $3,832,986 worth of shares (151,322 units at $25.33) as part of a pre-agreed trading plan (SEC Form 4)
- EVP & Chief Financial Officer Mountcastle David exercised 17,196 shares at a strike of $2.00 and sold $432,995 worth of shares (17,196 units at $25.18) as part of a pre-agreed trading plan (SEC Form 4)
- Privia Health Enters New Jersey